Buy Superior Quality HMG and HCG Products Online

Human chorionic gonadotropin is responsible for the process of sperm formation and affects the production of testosterone. Therefore, men are recommended to take HCG injections to increase sperm count and normalize testosterone levels.

Human menopausal gonadotropin is used by men for stimulation of spermatogenesis in azoospermia or oligoasthenospermia caused by primary or secondary hypogonadotropic hypogonadism (in combination with HCG). In hypogonadotropic hypogonadism, menopausal gonadotropin is used to stimulate spermatogenesis in cases where previous HCG therapy caused only an androgenic reaction without signs of spermatogenesis. At the same time, the administration of HCG at a dose of 2000 IU 2 times a week is continued along with the administration of menopausal gonadotropin (HMG) at a dose of 75 IU 3 times a week. This combination treatment is carried out for at least 4 months. If upon completion the patient does not experience an increase in spermatogenesis, treatment can be continued by administering HCG 2000 IU 2 times a week and menopausal gonadotropin (HMG) at a dose of 150 IU 3 times a week. The state of spermatogenesis is assessed monthly, and if there is no positive result over the next 3 months, treatment is stopped.

For idiopathic normogonadotropic oligospermia, menopausal gonadotropin in a dose of 75-150 IU is administered 3 times a week in combination with HCG in a dose of 5000 IU weekly. The course of treatment is 3 months.

To stimulate spermatogenesis, 1000-3000 IU of HCG is administered 3 times a week until the testosterone concentration in the blood normalizes. After this Menopausal Gonadotropin is administered 3 times a week for several months at a dose of 75-150 IU.